NuCana PLC (NCNA)

NASDAQ HEALTHCARE
$2.33 +2.64% RSI 54 Neutral Add Alert

Moving Averages

SMA 200
$3.50
Price below

Company Profile

NuCana plc, a clinical-stage biopharmaceutical company, is dedicated to the development of products for the treatment of cancer. The company is headquartered in Edinburgh, the United Kingdom.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$8.20M
Beta
2.176
Dividend Yield
0.00%
52-Week High
$40
52-Week Low
$1.33

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 44.0
VRTX
Vertex Pharmaceuticals Inc
RSI 50.0
CRSP
CRISPR Therapeutics AG
RSI 55.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 66.0
MRNA
Moderna Inc
RSI 41.0
VKTX
Viking Therapeutics Inc
RSI 48.0
SRPT
Sarepta Therapeutics Inc
RSI 42.0
EDIT
Editas Medicine Inc
RSI 59.0
IOVA
Iovance Biotherapeutics Inc
RSI 54.0
NVAX
Novavax Inc
RSI 60.0

Data last updated: May 13, 2026 at 11:34 PM EDT

Track NCNA for free

Get e-mail RSI alerts when NuCana PLC enters oversold or overbought territory. Free forever.

Add Alert